Do analysts rate UTMD or CERS?

Cerus has a consensus price target of $4.00, suggesting a potential upside of 30.29%. Given Cerus' stronger consensus rating and higher probable upside, analysts clearly believe Cerus is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cerus 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Do analysts prefer UTMD or OSUR?

OraSure Technologies has a consensus target price of $3.00, indicating a potential downside of 29.58%. Given OraSure Technologies' higher possible upside, analysts plainly believe OraSure Technologies is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 OraSure Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts rate UTMD or ANIK?

Anika Therapeutics has a consensus target price of $17.00, suggesting a potential upside of 9.54%. Given Anika Therapeutics' higher probable upside, analysts plainly believe Anika Therapeutics is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Anika Therapeutics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend UTMD or WST?

West Pharmaceutical Services has a consensus price target of $363.17, indicating a potential upside of 1.39%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts plainly believe West Pharmaceutical Services is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 West Pharmaceutical Services 0 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 2 Strong Buy rating(s) 3.00

Do analysts recommend COO or UTMD?

Cooper Companies currently has a consensus price target of $81.85, suggesting a potential upside of 19.47%. Given Cooper Companies' stronger consensus rating and higher probable upside, analysts plainly believe Cooper Companies is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cooper Companies 3 Sell rating(s) 5 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.38 Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Utah Medical Products (UTMD) Competitors

$68.25 -1.76 (-2.51%)

Closing price 07/14/2026 04:00 PM Eastern

Extended Trading

$68.25 +0.00 (+0.00%)

As of 04:09 AM Eastern

Compare

UTMD vs. CERS, OSUR, ANIK, WST, and COO

Should you buy Utah Medical Products stock or one of its competitors? MarketBeat compares Utah Medical Products with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), and Cooper Companies (COO). These companies are all part of the "health care supplies" industry.

How does Utah Medical Products compare to Cerus?

Utah Medical Products (NASDAQ:UTMD) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment.

Utah Medical Products has a net margin of 28.90% compared to Cerus' net margin of -4.41%. Utah Medical Products' return on equity of 9.13% beat Cerus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	28.90%	9.13%	8.86%
Cerus	-4.41%	-15.18%	-4.38%

Utah Medical Products has higher earnings, but lower revenue than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.63	$11.29M	$3.38	20.19
Cerus	$206.13M	2.98	-$15.63M	-$0.05	N/A

Cerus has a consensus price target of $4.00, suggesting a potential upside of 30.29%. Given Cerus' stronger consensus rating and higher probable upside, analysts clearly believe Cerus is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cerus	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Cerus had 4 more articles in the media than Utah Medical Products. MarketBeat recorded 5 mentions for Cerus and 1 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 0.93 beat Cerus' score of 0.80 indicating that Utah Medical Products is being referred to more favorably in the media.

Company	Overall Sentiment
Utah Medical Products	Positive
Cerus	Positive

Utah Medical Products has a beta of 0.36, meaning that its stock price is 64% less volatile than the broader market. Comparatively, Cerus has a beta of 1.77, meaning that its stock price is 77% more volatile than the broader market.

69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 78.4% of Cerus shares are owned by institutional investors. 8.0% of Utah Medical Products shares are owned by company insiders. Comparatively, 5.3% of Cerus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Utah Medical Products beats Cerus on 9 of the 16 factors compared between the two stocks.

How does Utah Medical Products compare to OraSure Technologies?

Utah Medical Products (NASDAQ:UTMD) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Utah Medical Products has higher earnings, but lower revenue than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.63	$11.29M	$3.38	20.19
OraSure Technologies	$115.02M	2.55	-$68.73M	-$1.04	N/A

OraSure Technologies has a consensus target price of $3.00, indicating a potential downside of 29.58%. Given OraSure Technologies' higher possible upside, analysts plainly believe OraSure Technologies is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 8.0% of Utah Medical Products shares are owned by insiders. Comparatively, 4.7% of OraSure Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Utah Medical Products has a net margin of 28.90% compared to OraSure Technologies' net margin of -66.42%. Utah Medical Products' return on equity of 9.13% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	28.90%	9.13%	8.86%
OraSure Technologies	-66.42%	-18.57%	-15.71%

In the previous week, Utah Medical Products and Utah Medical Products both had 1 articles in the media. OraSure Technologies' average media sentiment score of 1.31 beat Utah Medical Products' score of 0.93 indicating that OraSure Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Utah Medical Products	Positive
OraSure Technologies	Positive

Utah Medical Products has a beta of 0.36, suggesting that its stock price is 64% less volatile than the broader market. Comparatively, OraSure Technologies has a beta of 1.01, suggesting that its stock price is 1% more volatile than the broader market.

Summary

Utah Medical Products beats OraSure Technologies on 9 of the 14 factors compared between the two stocks.

How does Utah Medical Products compare to Anika Therapeutics?

Utah Medical Products (NASDAQ:UTMD) and Anika Therapeutics (NASDAQ:ANIK) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

In the previous week, Anika Therapeutics had 2 more articles in the media than Utah Medical Products. MarketBeat recorded 3 mentions for Anika Therapeutics and 1 mentions for Utah Medical Products. Anika Therapeutics' average media sentiment score of 1.28 beat Utah Medical Products' score of 0.93 indicating that Anika Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Utah Medical Products	Positive
Anika Therapeutics	Positive

Utah Medical Products has a beta of 0.36, indicating that its share price is 64% less volatile than the broader market. Comparatively, Anika Therapeutics has a beta of 0.23, indicating that its share price is 77% less volatile than the broader market.

Anika Therapeutics has a consensus target price of $17.00, suggesting a potential upside of 9.54%. Given Anika Therapeutics' higher probable upside, analysts plainly believe Anika Therapeutics is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Anika Therapeutics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Utah Medical Products has a net margin of 28.90% compared to Anika Therapeutics' net margin of -9.52%. Utah Medical Products' return on equity of 9.13% beat Anika Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	28.90%	9.13%	8.86%
Anika Therapeutics	-9.52%	-5.90%	-4.52%

Utah Medical Products has higher earnings, but lower revenue than Anika Therapeutics. Anika Therapeutics is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.63	$11.29M	$3.38	20.19
Anika Therapeutics	$112.82M	1.83	-$10.88M	-$0.79	N/A

69.6% of Utah Medical Products shares are held by institutional investors. Comparatively, 91.5% of Anika Therapeutics shares are held by institutional investors. 8.0% of Utah Medical Products shares are held by insiders. Comparatively, 12.1% of Anika Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Utah Medical Products beats Anika Therapeutics on 8 of the 15 factors compared between the two stocks.

How does Utah Medical Products compare to West Pharmaceutical Services?

Utah Medical Products (NASDAQ:UTMD) and West Pharmaceutical Services (NYSE:WST) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

West Pharmaceutical Services has a consensus price target of $363.17, indicating a potential upside of 1.39%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts plainly believe West Pharmaceutical Services is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00

Utah Medical Products has a net margin of 28.90% compared to West Pharmaceutical Services' net margin of 16.85%. West Pharmaceutical Services' return on equity of 19.03% beat Utah Medical Products' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	28.90%	9.13%	8.86%
West Pharmaceutical Services	16.85%	19.03%	14.06%

Utah Medical Products has a beta of 0.36, suggesting that its stock price is 64% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.16, suggesting that its stock price is 16% more volatile than the broader market.

69.6% of Utah Medical Products shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 8.0% of Utah Medical Products shares are held by company insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

West Pharmaceutical Services has higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.63	$11.29M	$3.38	20.19
West Pharmaceutical Services	$3.07B	8.23	$493.70M	$7.48	47.88

In the previous week, West Pharmaceutical Services had 8 more articles in the media than Utah Medical Products. MarketBeat recorded 9 mentions for West Pharmaceutical Services and 1 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 0.93 beat West Pharmaceutical Services' score of 0.73 indicating that Utah Medical Products is being referred to more favorably in the media.

Company	Overall Sentiment
Utah Medical Products	Positive
West Pharmaceutical Services	Positive

Utah Medical Products pays an annual dividend of $1.24 per share and has a dividend yield of 1.8%. West Pharmaceutical Services pays an annual dividend of $0.88 per share and has a dividend yield of 0.2%. Utah Medical Products pays out 36.7% of its earnings in the form of a dividend. West Pharmaceutical Services pays out 11.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Utah Medical Products has raised its dividend for 3 consecutive years. Utah Medical Products is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

West Pharmaceutical Services beats Utah Medical Products on 15 of the 20 factors compared between the two stocks.

How does Utah Medical Products compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and Utah Medical Products (NASDAQ:UTMD) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Cooper Companies has higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09B	3.26	$374.90M	$1.18	58.06
Utah Medical Products	$38.52M	5.63	$11.29M	$3.38	20.19

Cooper Companies has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market. Comparatively, Utah Medical Products has a beta of 0.36, suggesting that its stock price is 64% less volatile than the broader market.

Utah Medical Products has a net margin of 28.90% compared to Cooper Companies' net margin of 5.57%. Cooper Companies' return on equity of 10.88% beat Utah Medical Products' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
Utah Medical Products	28.90%	9.13%	8.86%

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by insiders. Comparatively, 8.0% of Utah Medical Products shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Cooper Companies had 13 more articles in the media than Utah Medical Products. MarketBeat recorded 14 mentions for Cooper Companies and 1 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 0.93 beat Cooper Companies' score of 0.89 indicating that Utah Medical Products is being referred to more favorably in the news media.

Company	Overall Sentiment
Cooper Companies	Positive
Utah Medical Products	Positive

Cooper Companies currently has a consensus price target of $81.85, suggesting a potential upside of 19.47%. Given Cooper Companies' stronger consensus rating and higher probable upside, analysts plainly believe Cooper Companies is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.38
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Cooper Companies beats Utah Medical Products on 10 of the 17 factors compared between the two stocks.

Get Utah Medical Products News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UTMD vs. The Competition

Export

Metric	Utah Medical Products	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$222.91M	$8.67B	$6.86B	$12.44B
Dividend Yield	1.77%	2.55%	2.68%	8.42%
P/E Ratio	20.19	15.65	27.01	24.38
Price / Sales	5.63	6.52	519.43	91.92
Price / Cash	15.69	18.09	48.59	59.36
Price / Book	1.83	3.56	10.80	6.33
Net Income	$11.29M	$228.19M	$3.59B	$331.02M
7 Day Performance	0.28%	-1.41%	-1.47%	-0.33%
1 Month Performance	-2.32%	-2.08%	2.78%	-1.29%
1 Year Performance	22.03%	2.26%	28.50%	21.30%

Utah Medical Products Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UTMD Utah Medical Products	1.5143 of 5 stars	$68.25 -2.5%	N/A	+20.4%	$222.91M	$38.52M	20.19	180	Gap Up
CERS Cerus	3.2002 of 5 stars	$3.22 -1.8%	$4.00 +24.2%	+111.7%	$657.21M	$206.13M	N/A	290	News Coverage Short Interest Decrease
OSUR OraSure Technologies	1.6404 of 5 stars	$4.32 -1.1%	$3.00 -30.6%	+38.8%	$300.87M	$115.02M	N/A	840	Positive News
ANIK Anika Therapeutics	2.4124 of 5 stars	$15.87 -1.0%	$17.00 +7.1%	+34.6%	$213.29M	$112.82M	N/A	300	Positive News
WST West Pharmaceutical Services	2.9966 of 5 stars	$356.15 -0.4%	$351.91 -1.2%	+59.4%	$25.27B	$3.07B	47.61	10,800	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UTMD) was last updated on 7/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Utah Medical Products (UTMD) Competitors

UTMD vs. CERS, OSUR, ANIK, WST, and COO

How does Utah Medical Products compare to Cerus?

Summary

How does Utah Medical Products compare to OraSure Technologies?

Summary

How does Utah Medical Products compare to Anika Therapeutics?

Summary

How does Utah Medical Products compare to West Pharmaceutical Services?

Summary

How does Utah Medical Products compare to Cooper Companies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UTMD vs. The Competition

Utah Medical Products Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Utah Medical Products (UTMD) Competitors

UTMD vs. CERS, OSUR, ANIK, WST, and COO

How does Utah Medical Products compare to Cerus?

Is UTMD or CERS more profitable?

Which has stronger valuation and earnings, UTMD or CERS?

Do analysts rate UTMD or CERS?

Does the media refer more to UTMD or CERS?

Which has more risk & volatility, UTMD or CERS?

Do insiders & institutionals have more ownership in UTMD or CERS?

Summary

How does Utah Medical Products compare to OraSure Technologies?

Which has preferable valuation and earnings, UTMD or OSUR?

Do analysts prefer UTMD or OSUR?

Do institutionals and insiders have more ownership in UTMD or OSUR?

Is UTMD or OSUR more profitable?

Does the media prefer UTMD or OSUR?

Which has more risk & volatility, UTMD or OSUR?

Summary

How does Utah Medical Products compare to Anika Therapeutics?

Does the media refer more to UTMD or ANIK?

Which has more volatility & risk, UTMD or ANIK?

Do analysts rate UTMD or ANIK?

Is UTMD or ANIK more profitable?

Which has preferable valuation and earnings, UTMD or ANIK?

Do insiders & institutionals have more ownership in UTMD or ANIK?

Summary

How does Utah Medical Products compare to West Pharmaceutical Services?

Do analysts recommend UTMD or WST?

Is UTMD or WST more profitable?

Which has more risk & volatility, UTMD or WST?

Do insiders & institutionals believe in UTMD or WST?

Which has stronger valuation & earnings, UTMD or WST?

Does the media refer more to UTMD or WST?

Is UTMD or WST a better dividend stock?

Summary

How does Utah Medical Products compare to Cooper Companies?

Which has stronger earnings & valuation, COO or UTMD?

Which has more volatility and risk, COO or UTMD?

Is COO or UTMD more profitable?

Do institutionals & insiders have more ownership in COO or UTMD?

Does the media prefer COO or UTMD?

Do analysts recommend COO or UTMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UTMD vs. The Competition

Utah Medical Products Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools